Small-Molecule Drugs for Glaucoma: IOP-Lowering, Neuroprotective and Multi-Target Strategies
Glaucoma, a leading cause of irreversible blindness worldwide, is primarily driven by elevated intraocular pressure (IOP) and retinal ganglion cell (RGC) apoptosis. Small-molecule agents, owing to their high target specificity and excellent ocular tissue penetration, remain the cornerstone of clinical management. Thi...